Veracyte Inc (VCYT)

Net profit margin

Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Net income (ttm) US$ in thousands 26,335 33,049 24,138 -9,268 -54,041 -68,177 -71,997 -47,548 -26,653 -27,783 -36,560 -43,244 -48,650 -48,156 -75,563 -73,079 -63,074 -65,061 -34,909 -34,323
Revenue (ttm) US$ in thousands 479,129 463,393 445,764 425,331 399,579 375,473 361,051 343,149 328,633 311,175 296,536 283,575 268,353 250,594 219,514 186,714 157,465 123,064 117,483 112,677
Net profit margin 5.50% 7.13% 5.41% -2.18% -13.52% -18.16% -19.94% -13.86% -8.11% -8.93% -12.33% -15.25% -18.13% -19.22% -34.42% -39.14% -40.06% -52.87% -29.71% -30.46%

June 30, 2025 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $26,335K ÷ $479,129K
= 5.50%

The net profit margin of Veracyte Inc. demonstrates a trajectory from significant losses toward periods of marginal profitability and eventual positive margins. Initially, during the fiscal quarters ending September 30, 2020, to June 30, 2022, the company experienced substantial negative net profit margins, ranging from -30.46% to -8.11%, indicating persistent unprofitability amidst potentially expanding revenues but higher costs or expenses.

From September 30, 2022, the net profit margin continued to improve, decreasing the magnitude of losses and reaching closer to breakeven, with the margin at -12.33% and subsequent quarters showing further reduction in net loss margins to as low as -8.93% in March 2023. This trend suggests operational improvements and cost management, alongside growth in revenues or improved pricing strategies.

The shift toward profitability becomes evident in the fiscal quarter ending December 31, 2024, where the net profit margin turns positive at 5.41%. This positive turn continues into early 2025, with March 31, 2025, registering a net profit margin of 7.13%, and the subsequent quarter maintaining a margin of approximately 5.50%.

Concluding this period, there is a notable improvement from persistent losses to sustained profitability, suggesting the company's operational efficiencies, revenue growth, or cost control measures have successfully translated into net income generation, culminating in positive profitability metrics in the most recent reported periods.